by NDASA | Sep 25, 2020 | Drug & Alcohol Testing, Feature, FMCSA
Nearly a year after the opening of the Federal Motor Carrier Safety Administration Drug & Alcohol Clearinghouse, NDASA members continue to report some confusion among their clients and business partners when it comes to the federally mandated national...
by NDASA | May 15, 2020 | Industry News, Uncategorized
Over the last months as most of us have been at home, the National Drug and Alcohol Screening Association (NDASA) has focused on what working in the ‘new normal’ will look like for our industry. We’ve written about it, spoken to the experts, hosted virtual...
by NDASA | May 12, 2020 | Substance Use
By Karen Pierce, Working Partners* The last two and a half months have been a giant roller coaster ride, and not a fun one. Employers have had to reexamine everything about their business – how to comply with ever-changing government guidelines, how to keep...
by NDASA | May 3, 2020 | Feature, Industry News
As we get ready to go back to work, businesses are facing new challenges and realities that are complicated by uncertainties about the progression of COVID-19. We know that it’s not just a matter of returning to normal. Continued social distancing, stringent cleaning...
by NDASA | Apr 16, 2020 | DOT, Feature
In recent weeks, the National Drug & Alcohol Screening Association (NDASA) has hosted a series of COVID-19 Townhall Discussions for its members in the drug and alcohol screening industry. The main takeaways from these meetings? Our members are passionate...
by NDASA | Mar 3, 2020 | DOT, Feature, NDASA Guidance
In light of recent reports that the Federal Motor Carriers Safety Administration (FMCSA) and other transportation modes are considering suspending random drug testing requirements during the COVID-19 health crisis, the National Drug and Alcohol Screening...
